Lipika Chablani: AAPS 2011 Profile and Podcast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lipika Chablani: AAPS 2011 Profile and Podcast


Lipika Chablani



Lipika Chablani

Add this Podcast feed to your media player



Lipika Chablani (PhD Candidate)
Department of Pharmaceutical Sciences
College of Pharmacy and Health Sciences
Mercer University, Atlanta, Georgia 30341, USA.
Thesis Title: Formulation of Novel Particulate Breast Cancer Vaccines using Spray Drying and In Vivo Evaluation of Vaccine Efficacy
M.S. in Industrial Pharmacy, College of Pharmacy and Health Sciences, Buies Creek, Campbell University, North Carolina 27506.
B.Pharm., K.M.Kundnani College of Pharmacy, Mumbai University, Mumbai, India 400018.

View Full Research Presentation

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here